SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 140 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2013. The put-call ratio across all filers is 1.16 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $6,968,000 | -52.9% | 89,197 | -45.7% | 0.00% | -50.0% |
| Q4 2021 | $14,804,000 | -5.3% | 164,396 | -2.8% | 0.01% | -11.1% |
| Q3 2021 | $15,640,000 | +15.0% | 169,113 | -3.3% | 0.01% | +12.5% |
| Q2 2021 | $13,602,000 | +65.2% | 174,974 | +58.3% | 0.01% | +60.0% |
| Q1 2021 | $8,236,000 | -61.9% | 110,510 | -13.0% | 0.01% | -64.3% |
| Q4 2020 | $21,645,000 | +31.4% | 126,956 | +8.2% | 0.01% | +16.7% |
| Q3 2020 | $16,476,000 | -12.0% | 117,325 | +0.5% | 0.01% | -14.3% |
| Q2 2020 | $18,726,000 | +19.4% | 116,788 | -27.1% | 0.01% | 0.0% |
| Q1 2020 | $15,680,000 | -15.3% | 160,293 | +11.8% | 0.01% | 0.0% |
| Q4 2019 | $18,502,000 | +104.1% | 143,382 | +19.2% | 0.01% | +100.0% |
| Q3 2019 | $9,063,000 | -56.3% | 120,328 | -11.8% | 0.01% | -58.8% |
| Q2 2019 | $20,721,000 | +33.2% | 136,365 | +4.5% | 0.02% | +30.8% |
| Q1 2019 | $15,552,000 | +17.0% | 130,482 | +7.2% | 0.01% | 0.0% |
| Q4 2018 | $13,289,000 | -37.3% | 121,773 | -7.2% | 0.01% | -31.6% |
| Q3 2018 | $21,184,000 | +24.6% | 131,161 | +2.0% | 0.02% | +18.8% |
| Q2 2018 | $16,996,000 | +78.0% | 128,581 | -0.2% | 0.02% | +77.8% |
| Q1 2018 | $9,546,000 | +12.6% | 128,843 | -15.4% | 0.01% | +12.5% |
| Q4 2017 | $8,479,000 | +37.4% | 152,386 | +12.0% | 0.01% | +14.3% |
| Q3 2017 | $6,173,000 | +66.7% | 136,098 | +23.9% | 0.01% | +75.0% |
| Q2 2017 | $3,702,000 | +14.7% | 109,818 | +0.7% | 0.00% | -20.0% |
| Q1 2017 | $3,227,000 | +12.8% | 109,034 | +4.6% | 0.01% | +25.0% |
| Q4 2016 | $2,860,000 | -68.6% | 104,249 | -29.6% | 0.00% | -71.4% |
| Q3 2016 | $9,098,000 | +250.1% | 148,157 | +8.7% | 0.01% | +250.0% |
| Q2 2016 | $2,599,000 | +418.8% | 136,273 | +431.2% | 0.00% | +300.0% |
| Q1 2016 | $501,000 | +84.9% | 25,654 | +265.4% | 0.00% | – |
| Q4 2015 | $271,000 | -40.0% | 7,021 | -50.1% | 0.00% | -100.0% |
| Q3 2015 | $452,000 | +95.7% | 14,079 | +85.7% | 0.00% | – |
| Q2 2015 | $231,000 | +4.1% | 7,582 | -50.6% | 0.00% | – |
| Q4 2014 | $222,000 | -38.0% | 15,334 | +27.6% | 0.00% | -100.0% |
| Q2 2014 | $358,000 | +30.2% | 12,013 | +106.3% | 0.00% | 0.0% |
| Q3 2013 | $275,000 | – | 5,823 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 2,999,453 | $413,414,607 | 13.31% |
| Casdin Capital, LLC | 1,160,000 | $159,882,800 | 13.17% |
| Ikarian Capital, LLC | 271,300 | $37,393,279 | 8.48% |
| Avoro Capital Advisors LLC | 3,650,000 | $503,079,500 | 7.46% |
| Evolutionary Tree Capital Management, LLC | 36,190 | $4,988,068 | 6.91% |
| Finepoint Capital LP | 122,757 | $16,919,597 | 6.46% |
| Ikarian Capital, LLC | 205,400 | $28,310,282 | 6.42% |
| Boxer Capital, LLC | 775,000 | $106,818 | 5.25% |
| Ghost Tree Capital, LLC | 125,000 | $17,229,000 | 5.09% |
| Logos Global Management LP | 220,000 | $30,322,600 | 4.34% |